This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
In the published article, there was an error. We incorrectly documented the experimental detection of MOTS-c through mass spectrometry and furnished a reference to substantiate this assertion. Nonetheless, despite the endeavors outlined in the cited study, endogenous MOTS-c still remains undetected by this “gold-standard” technology. The second reference is incorrect and should be removed.
A correction has been made to
“In case of circulating cell-free MOTS-c, mass spectrophotometry delivered gold-standard proof for MDP expression (
The corrected sentence appears below:
“In case of human MOTS-c, the “gold-standard” technology of liquid chromatography-mass spectrometry successfully detected the synthetic peptide used as positive assay control. However, the test failed to detect the circulating cell-free form of MOTS-c in human plasma samples irrespectively of the success in ELISA-based measurement (
The authors apologies for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.